Ken Beagley is a Professor of Immunology at the Institute of Health and Biomedical Innovation at Queensland University of Technology.
He has worked in the area of mucosal immunology for the past 30 years at the University of Alabama at Birmingham and the University of Newcastle prior to moving to QUT. Current research interests focus on immunity to sexually transmitted infections, in particular Chlamydia and genital herpes.
The aim of these studies is to understand the immune mechanisms that cause infertility and recurrent infections and those that protect against infection and to use this information to develop effective vaccines. This work involves the use of both mouse and guinea pig models of chlamydial and herpes infection and has been extended to include development of chlamydial vaccines to protect koalas.
Vaccine research includes the development of novel needle-free vaccination routes such as intranasal, sublingual and transcutaneous immunization, which target immunity to the female and male reproductive tracts to enhance the effectiveness of vaccines.
Other research interests include the effects of chlamydial infections on spermatogenesis, male infertility and ovarian function and modulation of immunity by sex hormones.